Articles from Millennium Medical Communications, Inc.

Article

Articles from Millennium Medical Communications, Inc.

Breast Cancer Express Report™

Update on Breast Cancer Treatments
Data Presented from The American Society of Clinical Oncology 2000 Annual Meeting
May 20–23, 2000/New Orleans, Louisiana
Re-printed with permission of Millennium Medical Communications

Current Options for the Treatment of Metastatic Breast Cancer
Data Presented from The American Society of Clinical Oncology 2000 Annual Meeting
May 20–23, 2000/New Orleans, Louisiana
Re-printed with permission of Millennium Medical Communications

Antidepressants Relieve Hot Flashes in Breast Cancer Survivors
Re-printed with permission of Millennium Medical Communications

Cardiology Express Report™ 

Does Hormone Replacement Therapy Benefits Women with Existing Heart Disease?
Data Presented from The 49th Annual Meeting of the American College of Cardiology 
March 12–15, 2000/Anaheim, California
Re-printed with permission of Millennium Medical Communications

Women with Heart Disease Face Tougher Battles than Men
Data Presented from The 49th Annual Meeting of the American College of Cardiology 
March 12–15, 2000/Anaheim, California
Re-printed with permission of Millennium Medical Communications

Osteoporosis Express Report™

Revolutionary Technique Can Repair Spinal Fractures and Relieve Pain
Data Presented from The World Congress on Osteoporosis
June 15–18, 2000/Chicago, Illinois
Re-printed with permission of Millennium Medical Communications

Exciting New Developments in Osteoporosis Treatment
Data presented at The World Congress on Osteoporosis
Chicago, IL/June 15–18, 2000
Re-printed with permission of Millennium Medical Communications

Women’s Health Express Report™

Assessing Options for Bone Maintenance and Osteoporosis Therapy
Data Presented from The World Congress on Osteoporosis 2000
June 15–18, 2000/Chicago, Illinois
Re-printed with permission of Millennium Medical Communications

Ovarian Cancer Protection Through Progestin-Induced Apoptosis
Data Presented from The XVI World Congress of the International Federation of Gynecology and Obstetrics (FIGO)
September 3–8, 2000/Washington, DC
Re-printed with permission of Millennium Medical Communications

The News on Hormone Replacement Therapy (HRT)
Data Presented from Primary Medicine Today (East)
September 15–17, 2000/Boston, Massachusetts
Re-printed with permission of Millennium Medical Communications

Drospirenone/Ethinyl Estradiol (Yasmin®): New Oral Contraceptive Promises Improved Tolerance and Less Side Effects
Data Presented from The XVI World Congress of the International Federation of Gynecology and Obstetrics (FIGO)
September 3–8, 2000/Washington, DC
Re-printed with permission of Millennium Medical Communications

Medroxyprogesterone Acetate/Estradiol Cypionate (Lunelle®): A New Development in Injectable Contraception
Data Presented from The XVI World Congress of the International Federation of Gynecology and Obstetrics (FIGO)
September 3–8, 2000/Washington, DC
Re-printed with permission of Millennium Medical Communications

Hormone Replacement and Menopause: What are the Issues?
Data Presented from The 22nd Annual Meeting of The American Society for Bone and Mineral Research
Re-printed with permission of Millennium Medical Communications

 

 

 

 

 

References:

This Report is a product of Millennium Medical Communications, Inc. ("MMC, Inc."), an independent, third-party organization providing educational information concerning current medical data and opinions presented at worldwide medical meetings. This Report is published in accordance with the Guidance for Industry: Industry Supported Scientific and Educational Activities, 62 Fed. Reg. 64,093, 64,096-99 (1997) adopted by the U.S. Department of Health and Human Services Food and Drug Administration. Pursuant to the foregoing standards, MMC, Inc. is solely responsible for selecting the topics discussed herein as well as the guest editor. The ideas and opinions expressed by the guest editor are those solely of the guest editor and do not necessarily reflect the opinions of Millennium Medical Communications, Inc. or any Sponsor hereto. This Report may contain data on products, product uses, indications, and dosages, which are not approved for use in the USA, Canada and the European Union and no endorsement is hereby made or intended by coverage of any unapproved use. The content of this report is intended for educational purposes only, and merely conveys scientific data presented at medical meetings. Approved product labeling should always be consulted for prescribing information. This Report is an independent and non-promotional report intended to provide accurate scientific and medical information for educational purposes. MMC, Inc. is not responsible for errors or omissions in reports. The production of this report was paid for by MMC, Inc.

© 2000 Millennium Medical Communications, Inc.

http://www.webhealthsearch.com

Contact Information:

Millennium Medical Communications

Bridget R. Dupuis, RN, BSN

Director of Business Development

bdupuis@webhealthsearch.com

(603) 929-5078 x 109

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
Hot flashes poorly impact sleep quality | Image Credit: intimmedicine.com
How to manage bone health in midlife women | Image Credit: - endocrine.org
Mary Jane Minkin, MD, discusses The Menopause Society 2023 Annual Meeting | Image Credit: Yale School of Medicine
Highlights from The Menopause Society 2023 Annual Meeting  | Image Credit: nursebarb.com
How fezolinetant changes management of hot flashes | Image Credit: medschool.cuanschutz.edu.
Fezolinetant effective against vasomotor symptoms | Image Credit: med.unc.edu
Matthew Zerden, MD
Marci Bowers, MD | Image Credit: Marcibowers.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.